28,177 Shares in Harrow, Inc. (NASDAQ:HROW) Purchased by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. acquired a new stake in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 28,177 shares of the company's stock, valued at approximately $1,267,000. Oppenheimer & Co. Inc. owned about 0.08% of Harrow as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the business. Corrado Advisors LLC bought a new position in Harrow during the third quarter valued at $331,000. Principal Financial Group Inc. bought a new position in Harrow during the third quarter valued at $329,000. Hills Bank & Trust Co bought a new position in Harrow during the third quarter valued at $107,000. Rice Hall James & Associates LLC lifted its holdings in shares of Harrow by 23.1% in the 3rd quarter. Rice Hall James & Associates LLC now owns 314,881 shares of the company's stock worth $14,157,000 after acquiring an additional 59,019 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in shares of Harrow by 64.2% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 6,825 shares of the company's stock worth $307,000 after acquiring an additional 2,668 shares during the last quarter. Institutional investors own 72.76% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on HROW shares. B. Riley restated a "buy" rating and issued a $50.00 target price on shares of Harrow in a report on Thursday, August 29th. Lake Street Capital raised their target price on shares of Harrow from $45.00 to $55.00 and gave the stock a "buy" rating in a report on Friday, October 4th. Finally, Craig Hallum raised their target price on shares of Harrow from $45.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, October 4th.

Harrow Trading Up 4.6 %

HROW stock traded up $1.73 during trading on Tuesday, hitting $39.70. The company had a trading volume of 488,802 shares, compared to its average volume of 514,353. The firm has a market capitalization of $1.41 billion, a P/E ratio of -42.23 and a beta of 0.76. Harrow, Inc. has a 52-week low of $8.72 and a 52-week high of $59.23. The company has a 50 day simple moving average of $47.89 and a 200-day simple moving average of $32.78. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 3.23.

About Harrow

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.